Nucleome Therapeutics Overview
- Founded
- 2019
- Status
- Private
- Employees
- 8
- Latest Deal Type
- Seed
- Latest Deal Amount
- $6.43M
- Investors
- 1
Nucleome Therapeutics General Information
Description
Developer of a nucleome decoding platform intended to unlock the non-coding genome for human health. The company's platform uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to identify disease affected pathways, enabling professionals to get genetically guided therapeutic to provide improved patients outcome.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- BioEscalator The Innovation Building
- The Old Road Campus, Roosevelt Drive, Headington
- Oxford OX3 7FZ
- England, United Kingdom
Nucleome Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 08-Aug-2019 | $6.43M | 00.000 | 000.00 | Completed | Startup |
Nucleome Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Nucleome Therapeutics Executive Team (3)
Nucleome Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Danuta Jeziorska Ph.D | Nucleome Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| James Davies | Nucleome Therapeutics | Co-Founder, Board Member & Board Observer | 000 0000 |
| James Hughes | Nucleome Therapeutics | Co-Founder & Board Member | 000 0000 |
| Lachlan MacKinnon | Oxford Sciences Innovation | Board Member | 000 0000 |
| Matthew Carpenter Ph.D | Self | Board Observer | 000 0000 |
Nucleome Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNucleome Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Oxford Sciences Innovation | Venture Capital | Minority | 000 0000 | 000000 0 |